Skip to main content
SpringerLink
Log in

Risk-Benefit Assessment of Nicotine Preparations in Smoking Cessation

  • Review Article
  • Risk-Benefit Assessment
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Nicotine influences many risk factors for cardiovascular disease, peptic ulcer disease, pregnancy complications and wound healing; however, whether nicotine itself actually causes or aggravates these diseases has not been well demonstrated. The safety of nicotine preparations for smoking cessation depends on the population, formulation, route of administration, dose, and frequency and duration of use. Major adverse effects of nicotine polacrilex and transdermal nicotine are very rare. Nicotine therapy usually doubles long term abstinence rates and is especially beneficial to highly dependent smokers. Nicotine replacements produce lower nicotine concentrations than cigarettes, and no tar and carbon monoxide; thus, it is difficult to justify absolute contraindications to these products. Decisions on the use of nicotine preparations in pregnancy, coronary disease, etc., must consider not only the medical status of patients but also their likelihood of stopping smoking with and without the help of nicotine replacement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Psychiatric Association (Eds). Diagnostic and statistical manual of mental disorders, 3rd ed. revised, American Psychiatric Association, Washington, 1987

    Google Scholar 

  • Belcher M, Jarvis MJ, Sutherland G. Nicotine absorption and dependence in an over the counter aid to stopping smoking. British Medical Journal 298: 570, 1989

    Article  PubMed  CAS  Google Scholar 

  • Benowitz NL. Clinical pharmacology of nicotine. Annual Review of Medicine 37: 21–32, 1986

    Article  PubMed  CAS  Google Scholar 

  • Benowitz N. Toxicity of nicotine: implications with regard to nicotine replacement therapy. In Pomerleau & Pomerleau (Eds) Nicotine replacement: a critical evaluation, pp. 187–217, Alan R. Liss, Inc., New York, 1988a

    Google Scholar 

  • Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. New England Journal of Medicine 319: 1318–1330, 1988b

    Article  PubMed  CAS  Google Scholar 

  • Benowitz NL. Central nervous system toxicity of nicotine. In Wald & Froggatt (Eds) Smoking and the low tar programme, pp. 5–10, Oxford University Press, Oxford, 1989

    Google Scholar 

  • Benowitz NL. Nicotine and coronary heart disease. Trends in Cardiovascular Medicine 1: 315–321, 1991a

    Article  PubMed  CAS  Google Scholar 

  • Benowitz NL. Nicotine replacement therapy during pregnancy. Journal of the American Medical Association 266: 3174–3177, 1991b

    Article  PubMed  CAS  Google Scholar 

  • Breslau N, Kilbey MM, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry 48: 1069–1074, 1991

    Article  PubMed  CAS  Google Scholar 

  • Christen AG, McDonald Jr JL. Safety of nicotine-containing gum. In Pomerleau et al. (Eds) Nicotine replacement: a critical evaluation, pp. 219–235, Alan R. Liss, Inc., New York, 1988

    Google Scholar 

  • DeGrandpre RJ, Bickel WK, Hughes JR, Higgins ST. Behavioral economics of drug self-administration III: reanalysis of the nicotine regulation hypothesis. Psychopharmacology 108: 1–10, 1992

    Article  PubMed  CAS  Google Scholar 

  • Fagerstrom K-O. Efficacy of nicotine chewing gum: a review. In Pomerleau et al. (Eds) Nicotine replacement: a critical evaluation, pp. 109–128, Alan R. Liss, Inc., New York, 1988

    Google Scholar 

  • Fagerstrom K-O, Hurt RD, Sawe U, Tonnesen P. Therapeutic use of nicotine patches: efficacy and safety. Journal of Smoking-Related Diseases, in press, 1992

    Google Scholar 

  • Fagerstrom K-O, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. Journal of Behavioral Medicine 12: 159–182, 1989

    Article  PubMed  CAS  Google Scholar 

  • Fiore MC, Novotny TE, Pierce JP, Hatzeandreu EJ, Patel KM, et al. Trends in cigarette smoking in the United States: the changing influence of gender and race. Journal of the American Medical Association 261: 49–55, 1989

    Article  PubMed  CAS  Google Scholar 

  • Glassman AH, Heizer JE, Covey LS, Cottier LB, Stetner F, et al. Smoking, smoking cessation, and major depression. Journal of the American Medical Association 264: 1546–1549, 1990

    Article  PubMed  CAS  Google Scholar 

  • Hajek P, Jarvis MJ, Belcher M, Sutherland G, Feyerabend C. Effect of smoke-free cigarettes on 24h cigarette withdrawal: a double-blind placebo-controlled study. Psychopharmacology 97: 99–102, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hale KL, Hughes JR, Oliveto AH, Heizer JE, Higgins ST, et al. Nicotine dependence in a population-based sample. In Harris (Ed.) Problems of drug dependence 1992, NIDA Research Monograph Series, US Government Printing Office, Washington, in press, 1992

    Google Scholar 

  • Hasenfratz M, Battig K. Nicotine absorption and the subjective and physiologic effects of nicotine toothpicks. Clinical Pharmacology and Therapeutics 50: 456–461, 1991

    Article  PubMed  CAS  Google Scholar 

  • Henningfield JE, Woodson PP. Behavioral and physiological aspects of nicotine dependence: the role of nicotine dose. Journal of Substance Abuse 1: 301–317, 1989

    Google Scholar 

  • Hoffman D. Nicotine, a tobacco-specific precursor for carcinogens. In Wald & Froggatt (Eds) Nicotine, smoking and the low tar programme, pp. 24–39, Oxford University Press, Oxford, 1989

    Google Scholar 

  • Hughes JR. Problems of nicotine gum. In Ockene (Ed.) Pharmacologic treatment of tobacco dependence: Proceedings of the World Congress, November 3–5, 1985, pp. 141–147, Institute for the Study of Smoking Behaviour and Policy, Cambridge, Massachusetts, 1986a

    Google Scholar 

  • Hughes JR. Genetics of smoking: a brief review. Behaviour Therapy 17: 335–345, 1986b

    Article  Google Scholar 

  • Hughes JR. Dependence potential and abuse liability of nicotine replacement therapies. In Pomerleau et al. (Eds) Nicotine replacement in the treatment of smoking, pp. 261–278, Plenum Press, New York, 1988a

    Google Scholar 

  • Hughes JR. Clonidine, depression and smoking cessation. Journal of the American Medical Association 254: 2901–2902, 1988b

    Article  Google Scholar 

  • Hughes JR. Long-term use of nicotine-replacement therapy. In Henningfield & Stitzer (Eds) New developments in nicotine-delivery systems, pp. 64–71, Carlton Publishers, New York, 1991

    Google Scholar 

  • Hughes JR. Pharmacotherapy for smoking cessation: a brief review. Journal of Consulting and Clinical Psychology 60: 689–697, 1992

    Article  PubMed  CAS  Google Scholar 

  • Hughes JR, Gust SW, Keenan RM, Skoog K, Fenwick JW, et al. Long-term use of nicotine versus placebo gum. Archives of Internal Medicine 151: 1993–1998, 1991

    Article  PubMed  CAS  Google Scholar 

  • Hughes JR, Higgins ST, Hatsukami DK. Effects of abstinence from tobacco: a critical review. In Kozlowski et al. (Eds) Research advances in alcohol and drug problems, Vol. 10, pp. 317–398, Plenum Press, New York, 1990

    Google Scholar 

  • Jarvis MJ, Hajek P, Russell MAH, West RJ. Nasal nicotine solution as an aid to cigarette withdrawal: a pilot clinical trial. British Journal of Addiction 82: 983–988, 1987

    Article  PubMed  CAS  Google Scholar 

  • Levine RL, Pepe PE, Fromm RE, Curka PA, Clark PA. Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests. Journal of the American Medical Association 267: 2935–2937, 1992

    Article  PubMed  CAS  Google Scholar 

  • Levy LS, Martin PA. Toxicology of nicotine — its role in the aetiology of cancer due to cigarette smoking and cardiovascular disease. In Wald & Froggatt (Eds) Nicotine, smoking and the low tar programme, pp. 13–23, Oxford University Press, Oxford, 1989

    Google Scholar 

  • McNeil AD, West RJ, Jarvis M, Jackson P, Bryant A. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology 90: 533–536, 1986

    Article  Google Scholar 

  • Newhouse P, Hughes JR. The role of nicotine and nicotine mechanisms in neuropsychiatric disease. British Journal of Addiction 86: 521–526, 1991

    Article  PubMed  CAS  Google Scholar 

  • Palmer KJ, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as an aid to smoking cessation. Drugs 44: 498–529, 1992

    Article  PubMed  CAS  Google Scholar 

  • Rennard SI, Daughton DM, Fortmann SP, Killen J, Petty T, et al. Transdermal nicotine enhances smoking cessation in coronary artery disease patients. Chest 100: 5S, 1991

    Google Scholar 

  • Russell MAH, Jarvis MJ, Sutherland G, Feyerabend C. Nicotine replacement in smoking cessation. Journal of the American Medical Association 257: 3262–3265, 1987

    Article  PubMed  CAS  Google Scholar 

  • US Department of Health and Human Services. The health consequences of smoking for women: a report of the Surgeon General, Office on Smoking and Health, Rockville, 1980

    Google Scholar 

  • US Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. A report of the Surgeon General, Office on Smoking and Health, Washington, 1984

    Google Scholar 

  • US Department of Health and Human Services. Toxicity of nicotine. In The health consequences of smoking: nicotine addiction. A report of the Surgeon General, pp. 590–611, US Government Printing Office, Washington, 1988a

    Google Scholar 

  • US Department of Health and Human Services. The health consequences of smoking: nicotine addiction, US Government Printing Office, Washington, 1988b

    Google Scholar 

  • US Department of Health and Human Services. The health consequences of smoking cessation: a report of the Surgeon General, US Government Printing Office, Washington, DC, 1990

    Google Scholar 

  • West RJ, Jarvis MJ, Russell MAH, Feyerabend C. Plasma nicotine concentrations from repeated doses of nasal nicotine solution. British Journal of Addiction 79: 443–445, 1984

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Psychiatry, Psychology and Family Practice, University of Vermont, Burlington, Vermont, USA

    John R. Hughes

Authors
  1. John R. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, J.R. Risk-Benefit Assessment of Nicotine Preparations in Smoking Cessation. Drug-Safety 8, 49–56 (1993). https://doi.org/10.2165/00002018-199308010-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199308010-00006

Keywords

Search

Navigation